Lung Cancer (EarlyCDT)

The EarlyCDT blood test measures your antibody response to 7 proteins produced by lung cancer cells. This can help find lung cancer at an early stage, before symptoms appear.

Sample
Blood
Collection
Venous draw at local venue
Results in
3–8 days
Biomarkers
1
Doctor reviewed
No
Tests for
  • EarlyCDT-Lung autoantibody panel

Test specifications

Sample type
blood
Collection method
venous draw at local venue
Turnaround time
3–8 days
Biomarkers tested
1
At-home test
No
Doctor reviewed
No
Gender focus
Both

What's tested

1 biomarker as listed by Bluecrest Wellness.

  • EarlyCDT-Lung autoantibody panel

About this test

The EarlyCDT blood test measures your antibody response to 7 proteins produced by lung cancer cells. This can help find lung cancer at an early stage, before symptoms appear.

The Lung Cancer (EarlyCDT) blood test checks for autoantibodies linked to lung cancer. These autoantibodies can appear before symptoms develop, helping to identify lung cancer at an early stage when treatment is more effective.

Our private Lung Cancer (EarlyCDT) test is a quick, easy, and accurate way to assess lung cancer risk. It can be added as an individual test to any of our existing packages.

Explore our packages and book online today. BOOK NOW

What is a Lung Cancer (EarlyCDT) test?

The Lung Cancer (EarlyCDT) test measures your immune response to seven proteins made by lung cancer cells. Your result is reported as low, moderate, or high risk.

If your result is moderate or high, further investigation with your GP is recommended.

Description provided by Bluecrest Wellness.

View all →